This trial will study whether a mindfulness meditation program can help African-American adults with type 2 diabetes improve their sleep and reduce stress, which may in turn reduce their risk of cardiovascular disease.
4 Primary · 3 Secondary · Reporting Duration: Change from baseline at 8 weeks
100 Total Participants · 2 Treatment Groups
Primary Treatment: Mindfunlness Meditation · No Placebo Group · N/A
Age 21 - 75 · All Participants · 7 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: